XML 14 R6.htm IDEA: XBRL DOCUMENT v3.21.4
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS - BRL (R$)
R$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
OPERATING ACTIVITIES          
Income (loss) from continuing operations R$ (270,983) R$ 218,709 R$ (447,081) R$ 622,534  
Adjustments for:          
Depreciation and amortization     1,301,510 1,127,954  
Depreciation and depletion of biological assets     754,783 645,551  
Result on disposal of property, plant and equipments and investment     (89,775) 24,279  
Write-down of inventories to net realizable value     68,965 96,916  
Provision for tax, civil and labor risks     73,645 260,311  
Financial results, net     2,346,976 1,233,191  
Tax recoveries and gains in tax lawsuits     (64,877) (294,890)  
Deferred income tax     (271,803) 187,959  
Employee profit sharing     65,255 159,669  
Other provisions     5,790 67,558  
Cash flow provided by operating activities before working capital     3,743,388 4,131,032  
Trade accounts receivable     849,748 827,060  
Inventories     (2,385,327) (1,980,815)  
Biological assets - current     (551,526) (295,995)  
Trade accounts payable     1,181,000 1,521,185  
Supply chain finance     443,092 282,351  
Cash generated by operating activities     3,280,375 4,484,818  
Investments in securities at FVTPL [1]     (46,695)  
Redemptions of securities at FVTPL [1]     66,797 102,172  
Interest received     61,872 77,686  
Payment of tax, civil and labor provisions     (269,704) (215,439)  
Derivative financial instruments     (35,097) 1,285,272  
Payment of income taxes     (152)  
Other operating assets and liabilities      (123,894) 378,166  
Net cash provided by operating activities     2,933,654 6,112,523  
INVESTING ACTIVITIES          
Investments in securities at amortized cost     (4,060)  
Redemptions of securities at amortized cost     166,112  
Investments in securities at FVTOCI [2]     (12,866)  
Redemptions of securities at FVTOCI [2]     86,059 26,352  
Redemption of restricted cash     400 285,622  
Additions to property, plant and equipment     (1,050,838) (542,600)  
Additions to biological assets - non-current     (922,801) (725,484)  
Proceeds from disposals of property, plant, equipments and investment     49,340 69,696  
Additions to intangible assets     (133,436) (74,384)  
Business combination, net of cash     (983,709)  
Sale of participation in subsidiaries with loss of control     132,951 38,546  
Acquisition of participation in joint ventures and subsidiaries     1,974 (819)  
Net cash used in investing activities     (2,670,874) (923,071)  
Net cash provided by investing activities from discontinued operations     (17,550)  
Net cash used in investing activities     (2,688,424) (923,071)  
FINANCING ACTIVITIES          
Proceeds from debt issuance     1,831,117 8,666,404  
Repayment of debt     (980,677) (6,360,934)  
Payment of interest     (1,021,601) (1,002,146) R$ 136,625
Payment of interest derivatives - fair value hedge     (1,086)  
Treasury shares acquisition     (106,070)  
Acquisition of non-controlling interests     (238,421) (100,390)  
Payment of lease liabilities     (548,911) (402,259)  
Net cash provided by (used in) financing activities     (959,579) 694,605  
EFFECT OF EXCHANGE RATE VARIATION ON CASH AND CASH EQUIVALENTS     27,568 1,276,745  
Net increase (decrease) in cash and cash equivalents     (686,781) 7,160,802  
Balance at the beginning of the period     7,576,625 4,237,785 4,237,785
Balance at the end of the period R$ 6,889,844 R$ 11,398,587 R$ 6,889,844 R$ 11,398,587 R$ 7,576,625
[1] FVTPL: Fair Value Through Profit and Loss.
[2] FVTOCI: Fair Value Through Other Comprehensive Income.